Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in Northern Thailand
Background: Warfarin has been widely used for the prevention and treatment of thromboembolism. Warfarin therapy depends on interaction between physiological, environmental, and genetic factors. Vitamin K epoxide reductase (VKORC1) and cytochrome P450 2C9 (CYP2C9) enzyme conjointly determine the warf...
Saved in:
Main Authors: | Srun Kuanprasert, Sakchai Dettrairat, Poonsub Palacajornsuk, Warunee Kunachiwa, Arintaya Phrommintikul |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77249097871&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/49265 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in Northern Thailand
by: Srun Kuanprasert, et al.
Published: (2018) -
Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in Northern Thailand
by: Kuanprasert S., et al.
Published: (2014) -
Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in Northern Thailand
by: Kuanprasert S., et al.
Published: (2014) -
Prevalence of coronary artery disease in patient with valvular heart disease.
by: O. Raungratanaamporn, et al.
Published: (2018) -
VKORC1, CYP2C9 Polymorphisms and clotting factors associated with warfarin maintenance dose
by: Alisara Sangviroon
Published: (2014)